![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1498, 2005-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab vs chemotherapy in metastatic breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab plus docetaxel in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab: In HER2 and Hormone Receptor Co-Positive Metastatic Breast Cancer
By Orman Jennifer S. Perry Caroline M.
Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. :